Human Genome Sciences And Lonza reach Agreement For BENLYSTA(R), New Treatment For S L E

by admin on July 15th, 2010

Hello there! If you are new here, you might want to subscribe to the RSS feed for updates on this topic.

Human Genome Sciences, Inc. (Nasdaq:HGSI) and Lonza announced an agreement for the future commercial supply of BENLYSTA® (belimumab), which is currently under regulatory review in the United States and Europe as a potential new treatment for systemic lupus erythematosus (SLE)…

read the whole story here

Tagged as: Benlysta · sle · Systemic lupus erythematosus